Company news

GH Research PLC news in 2026

GH Research PLC's news releases, calls and decks from 2026, newest first.

View company

GH Research Announces Publication of Phase 2a Postpartum Depression Results

June 3, 2026

GH Research Reports First Quarter 2026 Financial Results and Provides Business Update

May 13, 2026

GH Research Announces Pricing of $117.5 Million Underwritten Offering

April 29, 2026

GH Research Welcomes White House Executive Order to Accelerate Medical Treatments for Serious Mental Illness

April 20, 2026

GH Research Announces Publication of Phase 2b Results for Mebufotenin (GH001) in JAMA Psychiatry and Reports New Finding of Severity-Independent Efficacy in TRD

March 24, 2026

GH Research Reports Full Year 2025 Financial Results and Provides Business Update

March 4, 2026

GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026

January 4, 2026

GH Research to Announce IND Status for GH001

January 1, 2026

Decks in 2026